DK141171C - - Google Patents

Info

Publication number
DK141171C
DK141171C DK144076A DK144076A DK141171C DK 141171 C DK141171 C DK 141171C DK 144076 A DK144076 A DK 144076A DK 144076 A DK144076 A DK 144076A DK 141171 C DK141171 C DK 141171C
Authority
DK
Denmark
Application number
DK144076A
Other languages
Danish (da)
Other versions
DK144076A (US07223432-20070529-C00017.png
DK141171B (da
Inventor
Y Kamano
K Michishita
T Seki
I Tanaka
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50038914A external-priority patent/JPS51125372A/ja
Priority claimed from JP50052085A external-priority patent/JPS51128954A/ja
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of DK144076A publication Critical patent/DK144076A/da
Publication of DK141171B publication Critical patent/DK141171B/da
Application granted granted Critical
Publication of DK141171C publication Critical patent/DK141171C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK144076AA 1975-03-31 1976-03-30 Fremgangsmåde til fremstilling af 17alfa-acyloxy-21-halogenpregnaner. DK141171B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3891475 1975-03-31
JP50038914A JPS51125372A (en) 1975-03-31 1975-03-31 Aprocess for preparing pregnane steroid-17-ester-21-halides
JP5208575 1975-05-01
JP50052085A JPS51128954A (en) 1975-05-01 1975-05-01 Process for preparing 17-ester-21-halides of pregnate type s teroids

Publications (3)

Publication Number Publication Date
DK144076A DK144076A (US07223432-20070529-C00017.png) 1976-10-01
DK141171B DK141171B (da) 1980-01-28
DK141171C true DK141171C (US07223432-20070529-C00017.png) 1980-07-07

Family

ID=26378215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK144076AA DK141171B (da) 1975-03-31 1976-03-30 Fremgangsmåde til fremstilling af 17alfa-acyloxy-21-halogenpregnaner.

Country Status (14)

Country Link
US (1) US4113680A (US07223432-20070529-C00017.png)
CA (1) CA1044225A (US07223432-20070529-C00017.png)
CH (1) CH609709A5 (US07223432-20070529-C00017.png)
DE (1) DE2613875A1 (US07223432-20070529-C00017.png)
DK (1) DK141171B (US07223432-20070529-C00017.png)
ES (1) ES446411A1 (US07223432-20070529-C00017.png)
FR (1) FR2306214A1 (US07223432-20070529-C00017.png)
GB (1) GB1508517A (US07223432-20070529-C00017.png)
HU (1) HU174850B (US07223432-20070529-C00017.png)
IN (1) IN142583B (US07223432-20070529-C00017.png)
NL (1) NL7603249A (US07223432-20070529-C00017.png)
PT (1) PT64885B (US07223432-20070529-C00017.png)
SE (1) SE403380B (US07223432-20070529-C00017.png)
YU (1) YU54476A (US07223432-20070529-C00017.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742982C2 (de) * 1977-09-21 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4361558A (en) * 1980-04-29 1982-11-30 Ciba-Geigy Corporation Halogenated steroids
US4440689A (en) * 1981-07-22 1984-04-03 Mitsubishi Chemical Industries, Limited Acyloxysteroids and process for producing same
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
DE3915951C1 (US07223432-20070529-C00017.png) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
DK1305329T4 (da) * 2000-08-05 2015-06-15 Glaxo Group Ltd 6alpha, 9alpha-difluor-17alpha-(2-furanylcarboxyl)oxy-11beta-hydroxy-16alpha-methyl-3-oxo-androst-1,4-dien-17-carbothiosyre-S-fluormethylester som et antiinflammatorisk middel
PL366937A1 (en) * 2001-04-30 2005-02-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN109608511B (zh) * 2019-01-24 2021-05-04 上海新华联制药有限公司 泼尼松龙醋酸戊酸酯的化学合成工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE373332C (sv) * 1972-02-25 1977-07-25 Centralsug Ab Anordning for utvinning av fibermaterial ur blandat gods
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
CH609709A5 (US07223432-20070529-C00017.png) 1979-03-15
YU54476A (en) 1982-05-31
US4113680A (en) 1978-09-12
IN142583B (US07223432-20070529-C00017.png) 1977-07-30
FR2306214B1 (US07223432-20070529-C00017.png) 1981-04-30
ES446411A1 (es) 1979-02-01
SE403380B (sv) 1978-08-14
GB1508517A (en) 1978-04-26
NL7603249A (nl) 1976-10-04
DK144076A (US07223432-20070529-C00017.png) 1976-10-01
SE7603791L (sv) 1976-10-01
PT64885A (en) 1976-04-01
CA1044225A (en) 1978-12-12
FR2306214A1 (fr) 1976-10-29
PT64885B (en) 1977-11-17
DE2613875A1 (de) 1976-10-14
DK141171B (da) 1980-01-28
HU174850B (hu) 1980-03-28

Similar Documents

Publication Publication Date Title
DK141171C (US07223432-20070529-C00017.png)
JPS51110754A (US07223432-20070529-C00017.png)
FR2304388B1 (US07223432-20070529-C00017.png)
JPS5196970A (US07223432-20070529-C00017.png)
JPS5268538U (US07223432-20070529-C00017.png)
JPS51150103U (US07223432-20070529-C00017.png)
JPS5187121U (US07223432-20070529-C00017.png)
BG23303A1 (US07223432-20070529-C00017.png)
CH587716A5 (US07223432-20070529-C00017.png)
CH604436A5 (US07223432-20070529-C00017.png)
CH606303A5 (US07223432-20070529-C00017.png)
BG21639A1 (US07223432-20070529-C00017.png)
BG21511A1 (US07223432-20070529-C00017.png)
CH603139A5 (US07223432-20070529-C00017.png)
BG22009A1 (US07223432-20070529-C00017.png)
CH603072A5 (US07223432-20070529-C00017.png)
BG22271A1 (US07223432-20070529-C00017.png)
BG22304A1 (US07223432-20070529-C00017.png)
CH602891A5 (US07223432-20070529-C00017.png)
CH600814A5 (US07223432-20070529-C00017.png)
BG22887A1 (US07223432-20070529-C00017.png)
CH590123A5 (US07223432-20070529-C00017.png)
CH581939A5 (US07223432-20070529-C00017.png)
CH586611A5 (US07223432-20070529-C00017.png)
CH600458A5 (US07223432-20070529-C00017.png)

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed